The novel treatment of tirzepatide peptide represents a significant development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide502992.bloggerchest.com/42151562/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment